Aurobindo, Hetero, and Vivimed Class Action Settlements in Minnesota

All Aurobindo, Hetero, and Vivimed class action lawsuits and settlements available to Minnesota residents.

Minnesota residents have 1 active class action settlements involving Aurobindo, Hetero, and Vivimed that they can file claims for right now. Open settlements include $15.2M Valsartan, Losartan and Irbesartan class action settlement.

Class Action Buddy automatically files Aurobindo, Hetero, and Vivimed claims for Minnesota residents in under 60 seconds — no paperwork, no mailing, no proof of purchasey/proof-of-purchase/" style="color:#5D82F2;text-decoration:none;font-weight:500;">proof of purchase needed for most settlements.

About Aurobindo, Hetero, and Vivimed Class Actions in Minnesota

Minnesota residents affected by the $15.2 million Valsartan, Losartan and Irbesartan class action settlement involving pharmaceutical manufacturers Aurobindo, Hetero, and Vivimed have specific protections under state law. Minnesota's Consumer Fraud Act provides additional remedies beyond federal regulations, allowing residents to pursue damages for deceptive trade practices in pharmaceutical distribution. These companies supply generic medications widely distributed throughout Minnesota's healthcare system, including major hospital networks like Mayo Clinic and Allina Health. Minnesota operates under a notice statute for class actions, requiring courts to provide adequate notice to potential class members. The state's Department of Commerce actively monitors pharmaceutical settlements to ensure proper distribution of funds. Minnesota residents must typically submit claims within specified deadlines, often ranging from 60 to 180 days after final approval. The state's strong consumer protection framework means residents may be entitled to additional damages beyond the base settlement amount, particularly if they can demonstrate specific harm from contaminated blood pressure medications distributed through Minnesota pharmacies and healthcare providers.

How does Minnesota's Consumer Fraud Act affect my Aurobindo, Hetero, and Vivimed settlement claim?

Minnesota's Consumer Fraud Act provides additional protections beyond the federal class action settlement for pharmaceutical fraud. This means Minnesota residents may be eligible for enhanced damages if they purchased contaminated blood pressure medications from these manufacturers through Minnesota pharmacies.

Are Minnesota residents automatically included in the $15.2 million Valsartan settlement?

Minnesota residents who purchased Valsartan, Losartan, or Irbesartan manufactured by Aurobindo, Hetero, or Vivimed are likely included in the class. However, you must actively file a claim form and provide proof of purchase to receive compensation from the settlement fund.

What documentation do I need as a Minnesota resident to file my claim?

Minnesota residents need pharmacy records, prescription receipts, or insurance statements showing purchases of affected blood pressure medications. Minnesota's electronic prescription monitoring system may help verify your medication history if you lack original documentation.

Tips for Minnesota Residents Filing Aurobindo, Hetero, and Vivimed Claims

Minnesota residents should gather all pharmacy receipts and prescription records from 2018-2022 showing purchases of affected blood pressure medications. Contact your insurance company for detailed medication history if original receipts are unavailable. Minnesota's Prescription Monitoring Program database can verify medication purchases. Submit claims before deadlines, typically 60-180 days after court approval. Keep copies of all submitted documentation. Consider consulting with Minnesota-licensed attorneys familiar with pharmaceutical class actions, as the state's Consumer Fraud Act may provide additional remedies. Monitor the Minnesota Department of Commerce website for updates on pharmaceutical settlements affecting state residents.

More Minnesota Resources